Correlation Between Bionomics and Icosavax
Can any of the company-specific risk be diversified away by investing in both Bionomics and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionomics and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionomics Ltd ADR and Icosavax, you can compare the effects of market volatilities on Bionomics and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionomics with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionomics and Icosavax.
Diversification Opportunities for Bionomics and Icosavax
Pay attention - limited upside
The 3 months correlation between Bionomics and Icosavax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bionomics Ltd ADR and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Bionomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionomics Ltd ADR are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Bionomics i.e., Bionomics and Icosavax go up and down completely randomly.
Pair Corralation between Bionomics and Icosavax
If you would invest 364.00 in Bionomics Ltd ADR on December 30, 2024 and sell it today you would earn a total of 124.00 from holding Bionomics Ltd ADR or generate 34.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Bionomics Ltd ADR vs. Icosavax
Performance |
Timeline |
Bionomics ADR |
Risk-Adjusted Performance
Good
Weak | Strong |
Icosavax |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Bionomics and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bionomics and Icosavax
The main advantage of trading using opposite Bionomics and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionomics position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Bionomics vs. Accustem Sciences | Bionomics vs. Scisparc | Bionomics vs. Anebulo Pharmaceuticals | Bionomics vs. Pmv Pharmaceuticals |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
CEOs Directory Screen CEOs from public companies around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |